Understanding Attention Deficit Hyperactivity Disorder: Prevalence, Etiology, Diagnosis, and Therapeutic Approaches
Open Access
- 1 July 2024
- journal article
- research article
- Published by Al-Rafidain University College in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
- Vol. 7 (1) , 18-28
Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is classified using neoclassical systems such as the Diagnostic Statistical Manual of Mental Disorders-5 and the International Classification of Disease-10. There is significant evidence that pharmaceutical treatment, particularly stimulants, can reduce symptoms in the short term. Objective: To explore the comprehensive landscape of childhood to adulthood ADHD within the literature, which involves delving into its prevalence, etiology, risk factors, diagnosis, and treatment modalities. Methods: A literature search was conducted across articles published in English between 2011 and 2023; the literature extensively explored the prevalence, etiology, risk factors and diagnosis of the subject, with limited attention given to treatment between 2003 and 2023, utilizing electronic search engines such as Google Scholar, PubMed, IndMED, and MedIND, Scopus, and Web of Science. The search terms included "ADHD," "Attention Deficit and Hyperactivity Disorder," "Hyperactivity," "Child Psychiatry," "Hyperkinetic Disorder," "Attention Deficit Disorder," and "Worldwide.” Results: Out of the 400 papers evaluated, only 52 met the criteria encompassing prevalence, etiology, diagnosis, and treatment. Conclusions: ADHD is a prevalent neurodevelopmental disorder impacting individuals from childhood to adulthood, with varying prevalence rates globally. Methodological differences influence prevalence estimates, highlighting the need for standardized study designs. Both genetic and environmental factors contribute to its development. Management typically involves a combination of psychotherapy, lifestyle adjustments, and medication. However, refined diagnostic criteria and tailored treatment guidelines for children and adults are necessary. Continuous evaluation of interventions is crucial for optimizing care and enhancing the well-being of individuals with ADHD.Keywords
This publication has 85 references indexed in Scilit:
- Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During AdolescenceJAMA Network Open, 2023
- Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and SchizophreniaJAMA Psychiatry, 2022
- Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative reviewPsychopharmacology, 2021
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adultsCochrane Database of Systematic Reviews, 2021
- Association of Maternal Neurodevelopmental Risk Alleles With Early-Life ExposuresJAMA Psychiatry, 2019
- Prenatal maternal stress and risk of neurodevelopmental disorders in the offspring: a systematic review and meta-analysisSocial Psychiatry and Psychiatric Epidemiology, 2019
- Prenatal alcohol use as a risk for attention-deficit/hyperactivity disorderEuropean Archives of Psychiatry and Clinical Neuroscience, 2018
- Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016JAMA Network Open, 2018
- Genetic and environmental contributions to the association between ADHD and affective problems in early childhood—A Swedish population‐based twin studyAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2017
- Genetic and environmental contributions to the association between attention deficit hyperactivity disorder and alcohol dependence in adulthood: A large population‐based twin studyAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2015